Gene · 7112
TMPO: thymopoietin
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TMPO: thymopoietin. Genes, record 7112. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7112
On this page
Gene
Proteins2
Reviewed human proteins whose Swiss-Prot entry states the gene.
Patents53
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 67052 | P42166 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 67055 | P42167 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 16664 | P42167 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2587 | P42166 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 20581 | P42167 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2170 | P42166 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 4969 | P42167 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 4969 | P42167 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2170 | P42166 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 20581 | P42167 | Espacenet |
1 to 10 of 53
See all 53 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants880
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TMPO papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| ZIABC010309 | Nuclear Architecture and Disease | 7 | 2025 |
| P30CA013148 | Comprehensive Cancer Center Support Grant | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 3 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 2 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 2 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 880Source NIH's project files
See all 880 nih grantsPapers1,529
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoantibodies to the nuclear envelope: Functional anatomy of the HEp-2 cell substrate. | Autoimmun Rev | 2026 | 42567391 | PubTator, text mining | PubMed |
| The KIF13A-Rab11a axis: a key regulator of vesicle trafficking in cytokinesis. | EXCLI J | 2026 | 42459932 | PubTator, text mining | PubMed |
| Site-Specific Phosphoproteomics Uncovers Potential Regulatory Networks of NEK4 in DNA Damage Response and Cancer Progression. | OMICS | 2026 | 42340729 | PubTator, text mining | PubMed |
| Nuclear envelope proteins in cancer: revisiting the significance of LEM-domain proteins. | Front Cell Dev Biol | 2026 | 42099394 | PubTator, text mining | PubMed |
| B-type lamins maintain transcriptional homeostasis by spatially controlling chromatin-speckle proximity. | Nucleic Acids Res | 2026 | 41909953 | PubTator, text mining | PubMed |
| Leveraging Large and Diverse Biobanks to Evaluate Gene-Disease Associations in Hypertrophic Cardiomyopathy. | J Pers Med | 2026 | 41893039 | PubTator, text mining | PubMed |
| Lamin A/C as a Molecular Link Between Nuclear Organization, Chromatin Dynamics, and Tumor Progression. | Cells | 2026 | 41892292 | PubTator, text mining | PubMed |
| TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas. | Cell Rep Med | 2026 | 41850239 | PubTator, text mining | PubMed |
| LAP2 Isoform Profile in Heart Ageing and in Cardiac Cell Proliferation and Differentiation: Input From CRISPR-Cas9-mediated LAP2a Knockdown in H9C2. | Int J Med Sci | 2026 | 41799755 | PubTator, text mining | PubMed |
| Multimodality imaging of a rare case of apical hypertrophic cardiomyopathy with endomyocardial fibrosis and myocardial calcification: case report and literature review. | Front Cardiovasc Med | 2026 | 41788559 | PubTator, text mining | PubMed |
1 to 10 of 1,529
See all 1,529 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7112
GET https://conductscience.org/api/genes/v1/7112/patents?page=2